VIQURO: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
VIQURO
Largest movements
- Receivables after one year +€334,000
up €334,000 (+835.0%), from €40,000 to €374,000
- Deferred charges and accrued income +€9,420
up €9,420 (+1184.6%), from €795 to €10,215
- Debts after one year +€335,000
up €335,000 (+837.5%), from €40,000 to €375,000
- Accrued charges and deferred income +€9,717
up €9,717 (+1251.3%), from €777 to €10,493
- Financial charges +€8,945
up €8,945 (+1117.4%), from €801 to €9,746
- Financial income +€8,624
up €8,624 (+1084.6%), from €795 to €9,420
- Gross operating margin +€2,176
up €2,176 (+57.0%), from -€3,815 to -€1,639
- Other operating charges +€297
up €297 (+76.7%), from €387 to €684
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €211,687 | €554,754 | +€343,067 | +162.1% |
| Fixed assets | 21/28 | €170,000 | €170,000 | = | 0.0% |
| Financial fixed assets | 28 | €170,000 | €170,000 | = | 0.0% |
| Current assets | 29/58 | €41,687 | €384,754 | +€343,067 | +823.0% |
| Amounts receivable after more than one year | 29 | €40,000 | €374,000 | +€334,000 | +835.0% |
| Other amounts receivable | 291 | €40,000 | €374,000 | +€334,000 | +835.0% |
| Amounts receivable within one year | 40/41 | €714 | €175 | -€540 | -75.6% |
| Other amounts receivable | 41 | €714 | €175 | -€540 | -75.6% |
| Cash at bank and in hand | 54/58 | €177 | €364 | +€187 | +105.8% |
| Deferred charges and accrued income | 490/1 | €795 | €10,215 | +€9,420 | +1184.6% |
| Total equity and liabilities | 10/49 | €211,687 | €554,754 | +€343,067 | +162.1% |
| Equity | 10/15 | €170,910 | €168,261 | -€2,649 | -1.6% |
| Contributions | 10/11 | €180,000 | €180,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€9,090 | -€11,739 | -€2,649 | -29.1% |
| Amounts payable | 17/49 | €40,777 | €386,493 | +€345,717 | +847.8% |
| Amounts payable after more than one year | 17 | €40,000 | €375,000 | +€335,000 | +837.5% |
| Other amounts payable | 178/9 | €40,000 | €375,000 | +€335,000 | +837.5% |
| Amounts payable within one year | 42/48 | - | €1,000 | +€1,000 | |
| Trade debts | 44 | - | €1,000 | +€1,000 | |
| Suppliers | 440/4 | - | €1,000 | +€1,000 | |
| Accrued charges and deferred income | 492/3 | €777 | €10,493 | +€9,717 | +1251.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €0 | - | = | |
| Other operating charges | 640/8 | €387 | €684 | +€297 | +76.7% |
| Gross operating margin | 9900 | -€3,815 | -€1,639 | +€2,176 | +57.0% |
| Operating profit (loss) | 9901 | -€4,202 | -€2,323 | +€1,879 | +44.7% |
| Financial income | 75/76B | €795 | €9,420 | +€8,624 | +1084.6% |
| Recurring financial income | 75 | €795 | €9,420 | +€8,624 | +1084.6% |
| Financial charges | 65/66B | €801 | €9,746 | +€8,945 | +1117.4% |
| Recurring financial charges | 65 | €801 | €9,746 | +€8,945 | +1117.4% |
| Profit (loss) for the period before taxes | 9903 | -€4,207 | -€2,649 | +€1,558 | +37.0% |
| Profit (loss) for the period | 9904 | -€4,207 | -€2,649 | +€1,558 | +37.0% |
| Profit (loss) for the period to be appropriated | 9905 | -€4,207 | -€2,649 | +€1,558 | +37.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.